Free Trial

TScan Therapeutics (TCRX) Short Interest Ratio & Short Volume

TScan Therapeutics logo
$1.81 -0.03 (-1.63%)
Closing price 04:00 PM Eastern
Extended Trading
$1.82 +0.00 (+0.28%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TScan Therapeutics Short Interest Data

TScan Therapeutics (TCRX) has a short interest of 1.98 million shares, representing 4.52% of the float (the number of shares available for trading by the public). This marks a -12.78% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 409,973 shares to cover all short positions.

Current Short Interest
1,980,000 shares
Previous Short Interest
2,270,000 shares
Change Vs. Previous Month
-12.78%
Dollar Volume Sold Short
$2.87 million
Short Interest Ratio
3.2 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
56,590,000 shares
Float Size
43,830,000 shares
Short Percent of Float
4.52%
Today's Trading Volume
228,621 shares
Average Trading Volume
409,973 shares
Today's Volume Vs. Average
56%
Short Selling TScan Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for TScan Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TCRX Short Interest Over Time

TCRX Days to Cover Over Time

TCRX Percentage of Float Shorted Over Time

TScan Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20251,980,000 shares $2.87 million -12.8%4.5%3.2 $1.45
6/15/20252,270,000 shares $3.52 million +12.9%5.2%4 $1.55
5/31/20252,010,000 shares $2.88 million -12.6%4.6%3.5 $1.44
5/15/20252,300,000 shares $3.01 million +28.5%5.3%4.1 $1.31
4/30/20251,790,000 shares $2.87 million -1.7%4.1%3.9 $1.61
4/15/20251,820,000 shares $2.37 million -10.3%4.2%4.1 $1.30
3/31/20252,030,000 shares $2.80 million +6.8%4.7%4.9 $1.38
3/15/20251,900,000 shares $3.31 million -14.8%4.4%4.4 $1.74
2/28/20252,230,000 shares $4.68 million +11.5%5.2%4.8 $2.10
2/15/20252,000,000 shares $4.10 million +9.9%4.9%4.5 $2.05
1/31/20251,820,000 shares $4.68 million -9.0%4.2%4.5 $2.57
1/15/20252,000,000 shares $5.30 million -20.6%4.6%5 $2.65
12/31/20242,520,000 shares $7.66 million +7.2%5.8%6.4 $3.04
12/15/20242,350,000 shares $6.70 million +1.3%5.4%7.5 $2.85
11/30/20242,320,000 shares $11.07 million +0.9%5.3%9.4 $4.77
11/15/20242,300,000 shares $10.14 million +6.5%5.3%10.5 $4.41
10/31/20242,160,000 shares $9.81 million -3.6%5.2%9.6 $4.54
10/15/20242,240,000 shares $12.39 million +8.2%5.4%10.7 $5.53
9/30/20242,070,000 shares $10.31 million +15.0%5.0%9.3 $4.98
9/15/20241,800,000 shares $10.33 million +31.4%4.3%5 $5.74
8/31/20241,370,000 shares $7.71 million +9.6%3.3%3.8 $5.63
8/15/20241,250,000 shares $7.24 million +5.9%3.0%3.5 $5.79
7/31/20241,180,000 shares $8.43 million +15.7%2.9%3.3 $7.14
7/15/20241,020,000 shares $7.24 million +67.7%2.5%3 $7.10
6/30/2024608,200 shares $3.56 million +18.7%1.5%1.7 $5.85
6/15/2024512,400 shares $4.30 million +6.1%1.2%2.2 $8.40
5/31/2024482,800 shares $4.13 million +26.5%1.2%2.3 $8.55
5/15/2024381,800 shares $3.41 million -4.1%0.9%1.9 $8.93
4/30/2024398,000 shares $3.07 million -5.2%1.0%1.9 $7.72
4/15/2024419,700 shares $3.23 million +91.3%1.1%2.2 $7.69
3/31/2024219,400 shares $1.74 million +16.5%0.6%1.3 $7.94
3/15/2024188,300 shares $1.34 million +0.3%0.5%1.2 $7.12
2/29/2024187,700 shares $1.27 million -25.8%0.5%1.2 $6.75
2/15/2024252,900 shares $1.45 million +3.8%0.7%1.6 $5.74
1/31/2024243,600 shares $1.24 million -6.4%0.6%1.8 $5.11
1/15/2024260,300 shares $1.56 million -14.6%0.7%2 $6.00
12/31/2023304,700 shares $1.78 million -14.1%0.8%2.3 $5.83
12/15/2023354,700 shares $1.76 million -5.0%0.9%3.1 $4.95
11/30/2023373,300 shares $2.44 million -10.3%1.0%3.1 $6.53
11/15/2023416,000 shares $1.98 million -11.6%1.1%3.5 $4.76
Banks aren’t ready for this altcoin—are you? (Ad)

I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.

Discover our #1 crypto for the red-hot crypto market right now!
10/31/2023470,700 shares $1.81 million -10.5%1.2%4.4 $3.85
10/15/2023526,000 shares $1.77 million -7.2%1.4%5.1 $3.37
9/30/2023566,900 shares $1.45 million +50.5%1.5%4.7 $2.56
9/15/2023376,800 shares $1.09 million +12.5%1.0%2.9 $2.89
8/31/2023334,800 shares $796.82 thousand -5.0%0.9%2.5 $2.38
8/15/2023352,300 shares $739.83 thousand -9.8%0.9%1.4 $2.10
7/31/2023390,700 shares $875.17 thousand +9.0%0.9%0.3 $2.24
7/15/2023358,400 shares $756.22 thousand -5.6%0.8%0.2 $2.11
6/30/2023379,600 shares $949 thousand -5.6%0.9%0.3 $2.50
6/15/2023401,900 shares $1.09 million -19.6%1.0%0.3 $2.72
5/31/2023499,900 shares $1.15 million +19.8%1.4%0.4 $2.30
5/15/2023417,400 shares $1.68 million +365.9%2.9%0.3 $4.03
4/30/202389,600 shares $203.39 thousand -2.3%0.7%0.1 $2.27
4/15/202391,700 shares $200.82 thousand -24.7%0.7%0.6 $2.19
3/31/2023121,700 shares $255.57 thousand -21.0%0.9%0.8 $2.10
3/15/2023154,000 shares $403.48 thousand -2.0%1.2%1 $2.62
2/28/2023157,100 shares $463.45 thousand +4.0%1.2%1 $2.95
2/15/2023151,000 shares $407.70 thousand -50.3%1.2%1 $2.70
1/31/2023303,800 shares $552.92 thousand +109.7%3.3%2.2 $1.82
1/15/2023144,900 shares $318.78 thousand -1.6%1.6%1.1 $2.20
12/30/2022147,200 shares $228.16 thousand +1.1%1.6%5.8 $1.55
12/15/2022145,600 shares $276.64 thousand -5.9%1.6%7.4 $1.90
11/30/2022154,800 shares $334.37 thousand -3.9%1.7%8.5 $2.16
11/15/2022161,000 shares $431.48 thousand +14.9%1.8%8.5 $2.68
10/31/2022140,100 shares $378.27 thousand +151.5%1.5%7.3 $2.70
10/15/202255,700 shares $167.10 thousand -7.0%0.6%2.6 $3.00
9/30/202259,900 shares $182.70 thousand +12.6%0.7%3 $3.05
9/15/202253,200 shares $173.43 thousand +731.3%0.6%2.5 $3.26
8/31/20226,400 shares $17.60 thousand -96.8%0.1%0.3 $2.75
8/15/2022202,300 shares $681.75 thousand +12.3%2.2%9.9 $3.37
7/31/2022180,200 shares $791.08 thousand +8.8%2.0%1.9 $4.39
7/15/2022165,700 shares $565.04 thousand +5.5%1.8%1.7 $3.41
6/30/2022157,000 shares $493.77 thousand -0.2%1.7%1.5 $3.15
6/15/2022157,300 shares $493.92 thousand +17.0%1.7%1.3 $3.14
5/31/2022134,500 shares $430.40 thousand -41.9%1.5%1.1 $3.20
5/15/2022231,600 shares $576.68 thousand +830.1%2.5%1.9 $2.49
4/30/202224,900 shares $53.54 thousand +11.2%0.3%0.4 $2.15
4/15/202222,400 shares $58.91 thousand +1.8%0.3%0.5 $2.63
3/31/202222,000 shares $61.60 thousand +31.0%0.3%0.5 $2.80
3/15/202216,800 shares $60.65 thousand -35.6%0.2%0.5 $3.61
2/28/202226,100 shares $109.62 thousand -20.7%0.3%0.7 $4.20
2/15/202232,900 shares $177.66 thousand -39.1%0.4%1 $5.40
1/31/202254,000 shares $260.82 thousand -27.8%0.6%1.6 $4.83
1/15/202274,800 shares $377.74 thousand -21.8%0.7%2.2 $5.05
12/31/202195,700 shares $430.65 thousand -2.5%0.9%2.4 $4.50
12/15/202198,100 shares $485.60 thousand +4.0%1.0%2.3 $4.95
11/30/202194,300 shares $722.34 thousand +38.3%0.9%1.6 $7.66
11/15/202168,200 shares $554.47 thousand +32.2%0.7%1 $8.13
10/29/202151,600 shares $452.02 thousand +11.7%0.6%0.6 $8.76
10/15/202146,200 shares $311.85 thousand -50.1%0.5%0.5 $6.75
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
9/30/202192,500 shares $771.45 thousand +2,102.4%1.0%0.7 $8.34
9/15/20214,200 shares $28.85 thousand -67.4%0.1%0 $6.87
8/31/202112,900 shares $114.68 thousand -16.2%0.1%0.1 $8.89
8/13/202115,400 shares $158.93 thousand No Change0.2%0.1 $10.32

TCRX Short Interest - Frequently Asked Questions

What is TScan Therapeutics' current short interest?

Short interest is the volume of TScan Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 1,980,000 shares of TCRX short. 4.52% of TScan Therapeutics' shares are currently sold short. Learn More on TScan Therapeutics' current short interest.

What is a good short interest ratio for TScan Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TCRX shares currently have a short interest ratio of 3.0. Learn More on TScan Therapeutics's short interest ratio.

What is a good short interest percentage for TScan Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.52% of TScan Therapeutics' floating shares are currently sold short.

Is TScan Therapeutics' short interest increasing or decreasing?

TScan Therapeutics saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 1,980,000 shares, a drop of 12.8% from the previous total of 2,270,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is TScan Therapeutics' float size?

TScan Therapeutics currently has issued a total of 56,590,000 shares. Some of TScan Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TScan Therapeutics currently has a public float of 43,830,000 shares.

How does TScan Therapeutics' short interest compare to its competitors?

4.52% of TScan Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TScan Therapeutics: Heron Therapeutics, Inc. (25.71%), SNDL Inc. (1.21%), Vor Biopharma Inc. (4.19%), Aura Biosciences, Inc. (5.74%), Astria Therapeutics, Inc. (7.00%), Aerovate Therapeutics, Inc. (21.72%), Atea Pharmaceuticals, Inc. (5.49%), DBV Technologies S.A. (0.07%), Annexon, Inc. (10.39%), Olema Pharmaceuticals, Inc. (14.24%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short TScan Therapeutics stock?

Short selling TCRX is an investing strategy that aims to generate trading profit from TScan Therapeutics as its price is falling. TCRX shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TScan Therapeutics?

A short squeeze for TScan Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TCRX, which in turn drives the price of the stock up even further.

How often is TScan Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCRX, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:TCRX) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners